DNA adducts in squamous cell cervical carcinomas associated with HPV infection

European Journal of Gynaecological Oncology

Volumn 25, Issue 3, 2004, Pages 359-361

  Kwasniewska A ^a,d   Gozdzicka Jozefiak A ^b   Borzecki A ^a   Baranowski, W ^c  

^a Lublin Medical Academy   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

^c MILITARY INSTITUTE OF MEDICINE   (Poland)

^d NONE   (Poland)

Author keywords

Adducts; HPV 16 and or 18; Squamous cervical cancer

Indexed keywords

ADULT; ARTICLE; BIOASSAY; CARCINOGENESIS; CLINICAL ARTICLE; DNA ADDUCT; DNA DETERMINATION; DNA ISOLATION; FEMALE; HUMAN; HUMAN TISSUE; SQUAMOUS CELL CARCINOMA; THIN LAYER CHROMATOGRAPHY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERUS MYOMA; VIRUS INFECTION; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA ADDUCTS; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 2342460378     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J.L., Shah K.V.: "The causal relation between human papillomavirus and cervical cancer". J. Clin. Pathol., 2002, 55, 244.
2. IARC Human Papillomaviruses: "IARC monographs on the evaluation of carcinogenic risk to humans". Lyon, 1995, 64.
3. Poirier M.C.: "DNA adducts as exposure and indicator of cancer risk. Environ". Health Perspect., 1997, 105, 907.
4. Scully R.E., Bonfiglio T.A., Kurman R.J., Silverberg S.G., Wilkinson E.J.: "WHO international classification of tumors: histological typing of female genital tract tumors". New York, Springer-Verlag, 1996.
5. Tucker R.A., Johnson P.R., Reeves, Icenogle J.P.: "Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results". J. Virol. Methods, 1993, 43, 321.
6. Reddy M.V., Randerath K.: "Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diversed DNA adducts". Carcinogenesis, 1986, 7, 1543.
7. th International Papillomavirus Conference - program and abstracts book. Barcelona, Thau S.L., 2000, 125 (www.hpv2000.com).
8. Poirier M.C., Beland F.A.: "DNA adducts measurement and tumour incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment". Chem. Res. Toxicol., 1992, 5, 749.
9. Santella R.M.: "Immunologic methods for detection of carcinogen-DNA damage in humans". Cancer Epidemiol. Biomarkers Prev., 1999, 8, 733.
10. 32P-post-labeling assay". Carcinogenesis, 1992, 7, 1053.
11. Melikian A.A., Wang X., Waggoner S., Hoffman D.: "Comparative response of normal of human papillomavirus-16 immortalized human epithelial cervical cells to benzo[a]pyrene". Oncol. Rep., 1999, 6, 1371.
12. Simons A.M., Phillips D.H., Coleman D.V.: "Damage to DNA in cervical epithelium related to smoking tobacco". Br. Med. J., 1993, 29, 1444.
13. Simons A.M., van Herckenrode M., Rodriquez C.: "Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16 using exfoliated cervical cells". Br. J. Cancer, 1995, 71, 246.